<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01878721</url>
  </required_header>
  <id_info>
    <org_study_id>14824</org_study_id>
    <nct_id>NCT01878721</nct_id>
  </id_info>
  <brief_title>Positron Emission Tomography of Infection and Vasculitis</brief_title>
  <acronym>PETU</acronym>
  <official_title>Positron Emission Tomography of Infection and Vasculitis (PETU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the value of positron emission tomography/computed&#xD;
      tomography in various inflammatory conditions caused by bacterial infection or vasculitis.&#xD;
      Glucose analog FDG is sensitive to detect inflammation foci but we hypothesize that other&#xD;
      imaging agents such as PK11195 and Ga-citrate may have added value in certain applications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the value of PET/CT in various inflammatory&#xD;
      conditions caused by bacterial infection or vasculitis. Our aim is to:&#xD;
&#xD;
        1. investigate whether FDG (18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose) PET/CT and&#xD;
           68Ga-(Gallium-68) citrate PET/CT enable the early and accurate detection of metastatic&#xD;
           infection foci in Staphylococcus aureus bacteremia.&#xD;
&#xD;
        2. study the usefulness of FDG PET/CT in detection of endovascular infection in bacteremia&#xD;
           caused by Salmonella spp.&#xD;
&#xD;
        3. find an optimal FDG PET/CT protocol for detection of infectious endocarditis and&#xD;
           metastatic infection foci related to endocarditis.&#xD;
&#xD;
        4. study the value of FDG PET/CT in the diagnosis of infection of pacemaker or implantable&#xD;
           cardioverter defibrillator.&#xD;
&#xD;
        5. investigate the usefulness of FDG PET/CT, 68Ga-citrate PET/CT, and 11C- (carbon-11)&#xD;
           translocator protein ligand (PK11195) PET/CT in diagnosis of vasculitis and in imaging&#xD;
           of the magnitude of the vascular changes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">October 2021</completion_date>
  <primary_completion_date type="Actual">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of infection or vasculitis in PET images</measure>
    <time_frame>within 1 week after starting the treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Standardized uptake value of PET imaging agent at the site of infection or vasculitis</measure>
    <time_frame>within 1 week after starting the treatment</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">117</enrollment>
  <condition>Infection</condition>
  <condition>Vasculitis</condition>
  <arm_group>
    <arm_group_label>Staphylococcus aureus bacteremia</arm_group_label>
    <description>PET/CT in patients with Staphylococcus aureus bacteremia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Salmonella spp. bacteremia</arm_group_label>
    <description>PET/CT in patients with Salmonella spp. bacteremia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endocarditis</arm_group_label>
    <description>PET/CT in patients with infective endocarditis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pacemaker infection</arm_group_label>
    <description>PET/CT in patients with pacemaker infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vasculitis</arm_group_label>
    <description>PET/CT in patients with vasculitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET/CT</intervention_name>
    <description>positron emission tomography/computed tomography</description>
    <arm_group_label>Endocarditis</arm_group_label>
    <arm_group_label>Pacemaker infection</arm_group_label>
    <arm_group_label>Salmonella spp. bacteremia</arm_group_label>
    <arm_group_label>Staphylococcus aureus bacteremia</arm_group_label>
    <arm_group_label>Vasculitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of Turku University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adults with&#xD;
&#xD;
          -  Staphylococcus aureus bacteremia or&#xD;
&#xD;
          -  Salmonella spp. bacteremia or&#xD;
&#xD;
          -  infective endocarditis or&#xD;
&#xD;
          -  infection of pacemaker or implantable cardioverter defibrillator or&#xD;
&#xD;
          -  vasculitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  underage, pregnant, breastfeeding, handicapped or prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>FI-20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 10, 2013</study_first_submitted>
  <study_first_submitted_qc>June 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2013</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Anne Roivainen</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>PET/CT</keyword>
  <keyword>infection</keyword>
  <keyword>vasculitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Vasculitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

